% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Lehners:142466,
author = {N. Lehners$^*$ and E. Ellert and J. Xu$^*$ and J.
Hillengass and J. Leichsenring and A. Stenzinger and H.
Goldschmidt and M. Andrulis and M.-S. Raab$^*$},
title = {{O}ncogene-induced senescence: a potential breakpoint
mechanism against malignant transformation in plasma cell
disorders.},
journal = {Leukemia and lymphoma},
volume = {59},
number = {11},
issn = {1029-2403},
address = {London [u.a.]},
publisher = {Taylor $\&$ Francis Group},
reportid = {DKFZ-2019-00185},
pages = {2660 - 2669},
year = {2018},
abstract = {Oncogene-induced senescence (OIS) is a cellular
tumor-suppressive mechanism present in several premalignant
conditions. Here, we analyze the possible impact of OIS on
malignant transformation in plasma cell disorders. Tumor
samples from 125 patients with different disease stages were
analyzed immunohistochemically for expression of senescence
markers. Protein expression of cyclin-dependent kinase
inhibitor p21Cip1/Waf1 was significantly higher in
smoldering multiple myeloma (SMM) compared to monoclonal
gammopathy of undetermined significance (MGUS) (p = .02)
or symptomatic multiple myeloma (MM) (p = .005). SMM
plasma cells expressing p21Cip1/Waf1 were negative for Ki67,
consistent with senescence. While p27Kip1 was highly
expressed in healthy controls, MGUS and SMM, expression
decreased significantly in MM (p = .02). SMM plasma
cells displayed a mutually exclusive expression of
p21Cip1/Waf1/p27Kip1 suggesting compensatory mechanisms of
senescence. In conclusion, we found markers of cellular
senescence differentially expressed in SMM compared to MGUS
and MM supporting the hypothesis of OIS as a breakpoint
mechanism against malignant transformation in plasma cell
disorders.},
cin = {G170},
ddc = {610},
cid = {I:(DE-He78)G170-20160331},
pnm = {317 - Translational cancer research (POF3-317)},
pid = {G:(DE-HGF)POF3-317},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:29616856},
doi = {10.1080/10428194.2018.1443450},
url = {https://inrepo02.dkfz.de/record/142466},
}